AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

5,597.00p
   
  • Change Today:
    -9.00p
  • 52 Week High: 5,628.00
  • 52 Week Low: 4,325.00
  • Currency: UK Pounds
  • Shares Issued: 1,266.66m
  • Volume: 98,823
  • Market Cap: 70,895m
  • RiskGrade: 86

AstraZeneca Overview

A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

AstraZeneca Financials

Latest F'cast
Div Yield 3.8% 3.8%
Div Cover 1.5 1.2
Op Mrgn 18.2% 22.5%
ROCE 465.6%  
Latest F'cast
P/E 17.1 21.9
PEG n/a n/a
Pr/Revenue 4.6 4.3
Pr/Book 5.6  
Latest F'cast
Revenue -5.5% -36.4%
PBT -37.3% 29.5%
EPS -0.7% -20.8%
DPS n/a -42.1%

AstraZeneca Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-13 25,711.00 3,267.00 505.00¢ 9.2 n/a -26% 280.00¢ 6.0%
31-Dec-14 26,095.00 1,246.00 428.00¢ 13.9 n/a -15% 280.00¢ 4.7%
31-Dec-15 23,641.00 3,069.00 426.00¢ 14.1 n/a -0% 280.00¢ 4.7%
31-Dec-16 21,319.00 3,552.00 431.00¢ 13.4 13.4 +1% 280.00¢ 4.8%
31-Dec-17 20,152.00 2,227.00 428.00¢ 15.6 n/a -1% 280.00¢ 4.2%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

AstraZeneca Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-18 16,688.10 3,755.43 256.33p 21.9 n/a -21% 210.99p 3.8%
31-Dec-19 17,890.53 4,214.89 289.04p 19.4 1.5 +13% 212.76p 3.9%

Copyright © 2018 FactSet Research Systems Inc. All rights reserved.

AstraZeneca Company Announcements

Holding(s) in Company 18-Jul-2018 16:11 RNS
Holding(s) in Company 18-Jul-2018 12:00 RNS
Total Voting Rights 02-Jul-2018 15:00 RNS

Latest AstraZeneca Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 5,597.00p
Change Today -9.00p
% Change -0.16 %
52 Week High 5,628.00
52 Week Low 4,325.00
Volume 98,823
Shares Issued 1,266.66m
Market Cap 70,895m
RiskGrade 86

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
2.45% above the market average2.45% above the market average2.45% above the market average2.45% above the market average2.45% above the market average
90.48% above the sector average90.48% above the sector average90.48% above the sector average90.48% above the sector average90.48% above the sector average
Price Trend
57.42% above the market average57.42% above the market average57.42% above the market average57.42% above the market average57.42% above the market average
58.73% above the sector average58.73% above the sector average58.73% above the sector average58.73% above the sector average58.73% above the sector average
Income
40.85% above the market average40.85% above the market average40.85% above the market average40.85% above the market average40.85% above the market average
66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average
Growth
84.89% below the market average84.89% below the market average84.89% below the market average84.89% below the market average84.89% below the market average
95.24% below the sector average95.24% below the sector average95.24% below the sector average95.24% below the sector average95.24% below the sector average

What The Brokers Say

Strong Buy 18
Buy 2
Neutral 6
Sell 1
Strong Sell 5
Total 32
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  2nd Interim 1st Interim
Ex-Div 15-Feb-18 10-Aug-17
Paid 19-Mar-18 11-Sep-17
Amount 190.00¢ 90.00¢

Trades for 19-Jul-2018

Time Volume / Share Price
08:49 151 @ 5,597.00p
08:49 48 @ 5,597.00p
08:49 100 @ 5,596.37p
08:48 94 @ 5,598.00p
08:48 137 @ 5,598.00p

Top of Page